Literature DB >> 8082703

Modulation of striatal adenosine A1 and A2 receptors induces rotational behaviour in response to dopaminergic stimulation in intact rats.

P Popoli1, A Pèzzola, A S de Carolis.   

Abstract

The intraperitoneal injection of d-amphetamine (5 mg/kg i.p.), preceded (10 min before) by intrastriatal injection of an adenosine A2 receptor agonist (CGS 21680, 5-10 micrograms) or followed (5 min later) by an intrastriatal adenosine A1 receptor agonist (N6-cyclopentyladenosine, CPA, 30 micrograms), induced ipsilateral rotations in rats. The opposite effect (contralateral rotations) was observed with adenosine receptor antagonists (A2 antagonist, 3,7-dimethyl-1-propargylxanthine, DMPX, 10 micrograms; A1 antagonist, 8-cyclopentyl-1,3-dimethylxanthine, CPT, 2.5 micrograms). These results confirm that both adenosine A2 and A1 receptors modulate striatal dopaminergic neurotransmission.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8082703     DOI: 10.1016/0014-2999(94)90689-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

Review 1.  Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain.

Authors:  S Ferré; I Diamond; S R Goldberg; L Yao; S M O Hourani; Z L Huang; Y Urade; I Kitchen
Journal:  Prog Neurobiol       Date:  2007-05-01       Impact factor: 11.685

Review 2.  Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy.

Authors:  Detlev Boison; Philipp Singer; Hai-Ying Shen; Joram Feldon; Benjamin K Yee
Journal:  Neuropharmacology       Date:  2011-02-17       Impact factor: 5.250

3.  Superior working memory and behavioural habituation but diminished psychomotor coordination in mice lacking the ecto-5'-nucleotidase (CD73) gene.

Authors:  Armin Zlomuzica; Sandra Burghoff; Jürgen Schrader; Ekrem Dere
Journal:  Purinergic Signal       Date:  2012-12-29       Impact factor: 3.765

Review 4.  Modulators of nucleoside metabolism in the therapy of brain diseases.

Authors:  Detlev Boison
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

5.  Adenosine A(2A) receptors in psychopharmacology: modulators of behavior, mood and cognition.

Authors:  Hai-Ying Shen; Jiang-Fan Chen
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

6.  Adenosine A(2a) receptor antagonists: potential therapeutic and neuroprotective effects in Parkinson's disease.

Authors:  M Morelli; J Wardas
Journal:  Neurotox Res       Date:  2001-11       Impact factor: 3.911

7.  The adenosine A2A receptor is associated with methamphetamine dependence/psychosis in the Japanese population.

Authors:  Hideaki Kobayashi; Hiroshi Ujike; Nakao Iwata; Toshiya Inada; Mitsuhiko Yamada; Yoshimoto Sekine; Naohisa Uchimura; Masaomi Iyo; Norio Ozaki; Masanari Itokawa; Ichiro Sora
Journal:  Behav Brain Funct       Date:  2010-08-30       Impact factor: 3.759

Review 8.  Istradefylline to Treat Patients with Parkinson's Disease Experiencing "Off" Episodes: A Comprehensive Review.

Authors:  Amnon A Berger; Ariel Winnick; Alexandra Welschmeyer; Alicia Kaneb; Kevin Berardino; Elyse M Cornett; Alan D Kaye; Omar Viswanath; Ivan Urits
Journal:  Neurol Int       Date:  2020-12-08

Review 9.  Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets.

Authors:  Silvia Pasquini; Chiara Contri; Stefania Merighi; Stefania Gessi; Pier Andrea Borea; Katia Varani; Fabrizio Vincenzi
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

Review 10.  The Role of Adenosine Receptors in Psychostimulant Addiction.

Authors:  Inmaculada Ballesteros-Yáñez; Carlos A Castillo; Stefania Merighi; Stefania Gessi
Journal:  Front Pharmacol       Date:  2018-01-10       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.